Focused Alpha, LLC

SEC CIK: 0002105062
Latest filing: Aug 7, 2026

SEC filings (opens in a new tab)

TAK holding history

Takeda Pharmaceutical Co Ltd in every 13F filed by Focused Alpha, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TAK overview All 13F holders of TAK Full Q2 2026 holdings

Shares (Q2 2026): 18,897
Value: $302.9K
% of portfolio: 0.1%
Quarters held: 3; Since Q4 2025

Holdings of TAK by Focused Alpha, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	18,897	$302.9K	0.1%	+2,091+12.4%	Added	Holders
Q1 2026	16,806	$311.2K	0.1%	+2,626+18.5%	Added	Holders
Q4 2025	14,180	$221.1K	0.1%	–	No prior filing	Holders